{"nct_id":"NCT02078960","title":"A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study)","status":"TERMINATED","status_verified_date":"2021-11","start_date":"2014-10-09","start_date_type":"ACTUAL","primary_completion_date":"2017-07-06","primary_completion_date_type":"ACTUAL","completion_date":"2017-11-27","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TEVA"]}